News Focus
News Focus
Followers 3160
Posts 967885
Boards Moderated 152
Alias Born 09/04/2000

Re: mick post# 228101

Saturday, 01/02/2021 6:14:43 PM

Saturday, January 02, 2021 6:14:43 PM

Post# of 246423
Novavax (NVAX): This should be the next trial we hear about after Johnson & Johnson reports, and a lot of people are waiting to see how this recombinant protein candidate works out. These will be results from a trial in the UK - a US Phase 3 just launched this week. This one has much less rigorous storage requirements and is generally easier to manufacture, and it could be a big contributor if things work out.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today